Comment from Mark Mailhot
AnonymousOpposeAdvocacy
Summary: The Catholic Medical Association (CMA) opposes the loosening of federal safeguards on mifepristone, arguing that telemedicine chemical abortion lacks sufficient oversight, risks patient safety, and fails to provide adequate informed consent. They advocate for stricter regulations, including mandatory in-person physician consultations, reporting of all adverse effects, and disclosure of pregnancy continuance options.
As a physician, I oppose any loosening of the safeguards around the abortion pill (Mifepristone). The complication rate from this pill is estimated to be 10% or higher, yet complications are not required to be reported. The dispensing of this pill via telemedicine puts patients at risk.
Please see the attached document for more detailed information regarding objections to loosening restrictions.